Tobias Nordström
0000-0003-4915-7546
Publication & Citation Trends
Publications
0 total
Effect of a one-time sensitive screening intervention on prostate cancer mortality: The STHLM3 randomized trial.
Cited by 0
Semantic Scholar
Time to BCR and cancer-specific mortality after radiotherapy or prostatectomy: implications for risk stratification and follow-up
Cited by 0
Semantic Scholar
Trends and Patterns in Prostate Cancer Diagnostics During the Era of MRI Implementation – Real-world Evidence From a Population-based Study in the Stockholm Region, Sweden 2010–2023
Cited by 0
Semantic Scholar
Stockholm3-MRI population-based screening: Two-year outcomes comparing Stockholm3 and PSA.
Cited by 0
Semantic Scholar
AI-based Prediction of Biochemical Recurrence from Biopsy and Prostatectomy Samples
Cited by 0
Semantic Scholar
Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group.
Cited by 1
Semantic Scholar
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial
Cited by 1
Semantic Scholar
MP36-12 SEQUENTIAL SERIAL PROSTATE CANCER RISK STRATIFICATION WITH PSA, STOCKHOLM3, MRI, AND THE SWOP RISK CALCULATOR FOR BIOPSY SELECTION
Cited by 0
Semantic Scholar
Research Topics
Prostate Cancer Diagnosis and Treatment
(122)
Prostate Cancer Treatment and Research
(108)
Bladder and Urothelial Cancer Treatments
(17)
Urologic and reproductive health conditions
(17)
Statistical Methods in Clinical Trials
(14)
Affiliations
Karolinska University Hospital
University of Turku
University of California, San Francisco
Lund University
Washington University in St. Louis